Logos Global Management LP Kezar Life Sciences, Inc. Transaction History

Logos Global Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.58 - $17.13 $3.04 Million - $11.4 Million	-664,021 Reduced 41.14%	950,000 $7.86 Million
Q1 2022 May 16, 2022	BUY	$12.3 - $18.33 $2.02 Million - $3.01 Million	164,021 Added 11.31%	1,614,021 $26.8 Million
Q4 2021 Feb 14, 2022	SELL	$7.44 - $16.72 $19.7 Million - $44.3 Million	-2,650,000 Reduced 64.63%	1,450,000 $24.2 Million
Q3 2021 Nov 15, 2021	BUY	$4.85 - $9.73 $8.73 Million - $17.5 Million	1,800,000 Added 78.26%	4,100,000 $35.4 Million
Q2 2021 Aug 16, 2021	BUY	$4.93 - $6.46 $7.4 Million - $9.69 Million	1,500,000 Added 187.5%	2,300,000 $12.5 Million
Q1 2021 May 17, 2021	BUY	$5.24 - $6.99 $4.19 Million - $5.59 Million	800,000 New	800,000 $4.77 Million
Q1 2020 May 15, 2020	SELL	$2.77 - $5.75 $340,518 - $706,853	-122,931 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.5 - $4.26 $307,327 - $523,686	122,931 New	122,931 $493,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.